Neovasc Announces TSX Symbol Change to NVCN
March 10 2017 - 7:00AM
PR Newswire (Canada)
NASDAQ: NVCN
TSX: NVC
VANCOUVER, March 10, 2017 /CNW/ - Neovasc Inc.
("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX:
NVC) today announced that effective at the opening of trading on
Monday, March 13, 2017, shares of
Neovasc will commence trading on the Toronto Stock Exchange ("TSX")
under the symbol NVCN.
Following this change, the Company's TSX and Nasdaq Stock Market
symbols will be the same. No action is required to be taken
by current shareholders in connection with the change.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops,
manufactures and markets products for the rapidly growing
cardiovascular marketplace. Its products include the Neovasc
Reducer™, for the treatment of refractory angina which is not
currently available in the U.S. and has been available in
Europe since 2015 and the Tiara™,
for the transcatheter treatment of mitral valve disease, which is
currently under investigation in the U.S., Canada and Europe. The Company also sells a line of
advanced biological tissue products that are used as key components
in third-party medical products including transcatheter heart
valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
Copyright 2017 Canada NewsWire
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Jul 2023 to Jul 2024